ATE338142T1 - Methoden zur diagnose und behandlung von herzkrankheiten - Google Patents

Methoden zur diagnose und behandlung von herzkrankheiten

Info

Publication number
ATE338142T1
ATE338142T1 AT01902063T AT01902063T ATE338142T1 AT E338142 T1 ATE338142 T1 AT E338142T1 AT 01902063 T AT01902063 T AT 01902063T AT 01902063 T AT01902063 T AT 01902063T AT E338142 T1 ATE338142 T1 AT E338142T1
Authority
AT
Austria
Prior art keywords
methods
heart disease
diagnosis
treatment
treat
Prior art date
Application number
AT01902063T
Other languages
English (en)
Inventor
Mark C Fishman
Xiaolei Xu
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE338142T1 publication Critical patent/ATE338142T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT01902063T 2000-01-12 2001-01-12 Methoden zur diagnose und behandlung von herzkrankheiten ATE338142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17578700P 2000-01-12 2000-01-12

Publications (1)

Publication Number Publication Date
ATE338142T1 true ATE338142T1 (de) 2006-09-15

Family

ID=22641625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902063T ATE338142T1 (de) 2000-01-12 2001-01-12 Methoden zur diagnose und behandlung von herzkrankheiten

Country Status (8)

Country Link
US (2) US20020182599A1 (de)
EP (1) EP1254260B1 (de)
JP (1) JP2003533179A (de)
AT (1) ATE338142T1 (de)
AU (1) AU785046B2 (de)
CA (1) CA2396330A1 (de)
DE (1) DE60122673T2 (de)
WO (1) WO2001051666A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002103355A1 (fr) * 2001-06-18 2002-12-27 Takeda Chemical Industries, Ltd. Agents prophylactiques/remedes pour maladies cardiaques
WO2003052106A1 (en) * 2001-12-17 2003-06-26 Children's Medical Center Corporation Method of screening compounds
US20050214771A1 (en) 2002-11-25 2005-09-29 Roth Richard B Methods for identifying risk of breast cancer and treatments thereof
US7608458B2 (en) * 2004-02-05 2009-10-27 Medtronic, Inc. Identifying patients at risk for life threatening arrhythmias
EP1723432A1 (de) 2004-02-05 2006-11-22 Medtronic, Inc. Verfahren und vorrichtung zur identifizierung von patienten in gefahr durch lebensbedrohliche arrhythmien
US20050287574A1 (en) * 2004-06-23 2005-12-29 Medtronic, Inc. Genetic diagnostic method for SCD risk stratification
US8027791B2 (en) * 2004-06-23 2011-09-27 Medtronic, Inc. Self-improving classification system
US8335652B2 (en) * 2004-06-23 2012-12-18 Yougene Corp. Self-improving identification method
US20070179815A1 (en) * 2006-01-20 2007-08-02 Heartscreen America, Inc. Medical screening system and method
JP5099142B2 (ja) * 2007-10-02 2012-12-12 富士通株式会社 分析支援プログラム、分析支援装置、および分析支援方法
US20110143956A1 (en) * 2007-11-14 2011-06-16 Medtronic, Inc. Diagnostic Kits and Methods for SCD or SCA Therapy Selection
WO2009064970A1 (en) * 2007-11-14 2009-05-22 Medtronic, Inc. Genetic markers for scd or sca therapy selection
US20100317006A1 (en) * 2009-05-12 2010-12-16 Medtronic, Inc. Sca risk stratification by predicting patient response to anti-arrhythmics
US9476097B2 (en) 2011-04-11 2016-10-25 The Brigham And Women's Hospital, Inc. Structural mutations in titin cause dilated cardiomyopathy

Also Published As

Publication number Publication date
JP2003533179A (ja) 2003-11-11
CA2396330A1 (en) 2001-07-19
US20020182599A1 (en) 2002-12-05
EP1254260A4 (de) 2003-07-23
US20040265841A1 (en) 2004-12-30
DE60122673D1 (de) 2006-10-12
DE60122673T2 (de) 2007-07-12
WO2001051666A1 (en) 2001-07-19
EP1254260B1 (de) 2006-08-30
EP1254260A1 (de) 2002-11-06
AU785046B2 (en) 2006-09-07
AU2790701A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
DE60108230D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
ATE311226T1 (de) Die glycin-betain für seine antithrombotische verwendung
ATE420654T1 (de) Behandlung von muskeldystrophien und verwandter erkrankungen
ATE352311T1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE298246T1 (de) Aktiviertes protein c zur behandlung von pankreatitis
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
DE60226324D1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
WO2003028536A3 (en) Methods for diagnosing and treating heart disease
WO2002062204A3 (en) Methods for diagnosing and treating heart disease
DE60225845D1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
ATE339690T1 (de) Verfahren zum screening von verbindungen auf aktivität bei der behandlung einer mit osteoklasten zusammenhängenden knochenerkrankung
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
CY1110278T1 (el) Μεθοδος διαλογης παραγοντων ικανων να θεραπευουν την παχυσαρκια
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
FR2846658B1 (fr) Peptides pour la prevention, le diagnostic et le traitement de la leptospirose animale et/ou humaine.
ATE258064T1 (de) Verwendung von antileukoprotease zur behandlung von endometriose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties